| 查看: 2076 | 回复: 8 | ||||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | ||||
[交流]
关于Biomaterials投稿
|
||||
|
第一次投Biomaterials,有好多问题不是太懂,谁投过给些建议。 1.实验数据是不是放在文章的最后面 2.A template for the covering letter is found on the Biomaterials website.我没找到,想问一下你们在哪找到的 |
» 猜你喜欢
Cas 72-43-5需要30g,定制合成,能接单的留言
已经有8人回复
求助:我三月中下旬出站,青基依托单位怎么办?
已经有6人回复
北京211副教授,35岁,想重新出发,去国外做博后,怎么样?
已经有8人回复
磺酰氟产物,毕不了业了!
已经有5人回复
论文终于录用啦!满足毕业条件了
已经有25人回复
2026年机械制造与材料应用国际会议 (ICMMMA 2026)
已经有3人回复
自荐读博
已经有3人回复
不自信的我
已经有5人回复
投稿Elsevier的杂志(返修),总是在选择OA和subscription界面被踢皮球
已经有8人回复
» 本主题相关价值贴推荐,对您同样有帮助:
关于一篇文献的题目
已经有5人回复
2012 SCI impact factor 生物材料类 评点
已经有9人回复
论文投稿刊物选择
已经有1人回复
» 抢金币啦!回帖就可以得到:
博士去军队文职怎么样
+5/335
16年了,来看看大家
+1/198
诚征另一半
+1/153
供应德国EXAKT艾卡特半导体导热散热材料三辊研磨机50 PLUS
+1/92
深圳大学材料学院黄妍斐教授课题组诚招2026年秋季入学博士生
+1/91
美国密歇根州立大学林学系杜海顺课题组招收全奖博士生及联合培养博士生
+1/76
华中科技大学郭睿副教授建筑与能源科学课题组诚招博士研究生(2026.1.19截止)
+1/65
希望你在这里
+1/63
87 年东北小哥定居苏州(沪杭亦可),诚寻携手余生的你
+1/58
西北工业大学无人飞行器技术全国重点实验室拟招收电机/自动化方向博士1~2名
+1/30
SCI,计算机相关可以写
+1/25
SCI,计算机相关可以写
+1/21
SCI,计算机相关可以写
+1/20
杨老师招收联合培养硕士、博士生或客座学生
+1/19
吉林大学材料物理本科生求问调剂信息
+1/11
中科院深圳理工大学网络课题组招聘博后/RA/实习生
+1/9
合肥工业大学许婷婷老师招收2026年入学博士研究生,有机/高分子合成背景
+1/7
浙江大学傅杰团队(杰青)高薪招聘博士后1
+1/4
求博导收留
+1/1
废旧塑料热解油采购
+1/1
8楼2013-04-23 13:28:19
nono2009
超级版主 (文学泰斗)
-

专家经验: +21105 - SEPI: 10
- 应助: 28684 (院士)
- 贵宾: 513.911
- 金币: 2555220
- 帖子: 1602255
- 在线: 65200.9小时
- 虫号: 827383
★ ★
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+1 2012-11-18 09:04:24
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+1 2012-11-18 09:04:24
|
楼主是看的这里吗:http://www.elsevier.com/journals ... 2/guide-for-authors 这么没有查到你说的A template for the covering letter is found on the Biomaterials website |
2楼2012-11-17 19:30:02
3楼2012-11-17 22:01:53
★ ★ ★ ★ ★ ★
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+5 2012-11-18 09:19:43
esub: 回帖置顶 2013-04-24 17:07:15
小木虫: 金币+0.5, 给个红包,谢谢回帖
shmily1972: 金币+5 2012-11-18 09:19:43
esub: 回帖置顶 2013-04-24 17:07:15
|
亲,你可以在EES的主页上的右边栏上点Author declaration,然后就会直接下载一个word版本的author declaration,而 A template for the covering letter will be found at the end of this document:顺便给你复制了一个,因为好还不会用附件啊 We the undersigned declare that this manuscript is original, has not been published before and is not currently being considered for publication elsewhere. We would like to draw the attention of the Editor to the following publications of one or more of us that refer to aspects of the manuscript presently being submitted. Where relevant copies of such publications are attached. [CAN BE DELETED IF NOT RELEVANT] We wish to draw the attention of the Editor to the following facts which may be considered as potential conflicts of interest and to significant financial contributions to this work. [OR] We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed. We further confirm that the order of authors listed in the manuscript has been approved by all of us. We confirm that we have given due consideration to the protection of intellectual property associated with this work and that there are no impediments to publication, including the timing of publication, with respect to intellectual property. In so doing we confirm that we have followed the regulations of our institutions concerning intellectual property. We further confirm that any aspect of the work covered in this manuscript that has involved either experimental animals or human patients has been conducted with the ethical approval of all relevant bodies and that such approvals are acknowledged within the manuscript. [CAN BE DELETED IF NOT RELEVANT] We understand that the Corresponding Author is the sole contact for the Editorial process (including Editorial Manager and direct communications with the office). He/she is responsible for communicating with the other authors about progress, submissions of revisions and final approval of proofs. We confirm that we have provided a current, correct email address which is accessible by the Corresponding Author and which has been configured to accept email from biomaterials@online.be. Signed by all authors as follows: [LIST AUTHORS AND DATED SIGNATURES ALONGSIDE] |
4楼2012-11-17 22:38:10









回复此楼